San Francisco Community Clinic Consortium

Summary

What do they do? SFCCC’s Street Outreach Services describes mobile healthcare, including wound care. This does not establish a sustained venous-ulcer protocol. The model is for clinically assessed, eligible venous disease—not every wound or swollen leg. Federal health-center funding and other clinical providers must be reconciled. More

Why this approach interests us

• Sustained, appropriate venous-ulcer care may produce more time without an ulcer.

Our main reservations

• The treatment trial improved ulcer-free time but not generic health utility. Local protocol and course delivery are unverified.

What do you get for your dollar?

Our provisional best estimate is $24,677,966 per better life:10 additional QALYs. This is a narrow, highly uncertain health-only model, not the organization’s overall impact or a verified donation offer. Inspect the assumptions →

best guess

$24,677,966 — USD/10 incremental QALYs; conditional donor budget

positive scenarios

$550,265–$5,200,000,000 — Joint scenarios, not confidence intervals

health evidence

Null is plausible — A positive best guess does not rule out no added health

funding room

Unverified — Public contracts are not marginal donation offers

1. What do they do?

SFCCC’s Street Outreach Services describes mobile healthcare, including wound care. This does not establish a sustained venous-ulcer protocol. The model is for clinically assessed, eligible venous disease—not every wound or swollen leg. Federal health-center funding and other clinical providers must be reconciled.

Scope of this review. Count each patient pathway once. Do not add mortality, housing, substance-use treatment or other overlapping benefits without separate causal models and reconciliation.

2. Monitoring and information sharing

3. Qualitative assessment

Sustained, appropriate venous-ulcer care may produce more time without an ulcer.

Key reservations

• Existing usual care may already deliver effective compression. Clinic location alone is not the active ingredient.
• A short twelve-contact pilot cannot inherit the complete one-year package effect without a separate model.
• No sepsis, amputation or mortality credit is inferred from generic wound-treatment encounters.

Benefits not included in our estimate

• Healthcare savings as donor cash
• Unmodeled mortality reduction
• Independent housing and substance-use benefits
• Unpriced public or volunteered resources

4. What do you get for your dollar?

$24,677,966 per10 QALYs

Central gross donor cost isUSD3,500 for a full-year pathway.5.9 extra ulcer-free weeks /52 ×.05 assumed utility ×.5 transfer ×.5 financing gives .00141827 QALY. The utility bridge is judgmental; the trial did not demonstrate a generic utility advantage.

A better life is our comparison unit of 10 additional quality-adjusted life years (QALYs), potentially spread across people. These are uncertain estimates, not measured returns or verified donation offers.

How we calculate the estimate

DOLLARS PER BETTER LIFE: 10 ×course cost / {financing × [ulcer-free weeks /52 ×utility gap ×transfer −extra net harm]}
$24,677,966 per10 QALYs

Hypothetical course budget—not a verified funding tranche

• Favorable full-course: $550,265 per10 QALYs. 0.01817 conditional QALY per offered course.
• Central: $24,677,966 per10 QALYs. 0.001418 conditional QALY per offered course.
• Pessimistic: $5,200,000,000 per10 QALYs. 0.00001154 conditional QALY per offered course.

Uncertainty. Zero actual utility benefit, unchanged care or fully replaced financing gives no finite positive price. Net harms can make health negative; this is not a negative-price bargain.

5. Funding and previous grants

Need a named clinically eligible cohort, additional capacity, all payer contributions and measured health difference versus actual usual care.

Constructed course:32 planned contacts ×(.5 RN hour ×USD100 ×1.3 loading +USD30 supplies) +USD460 assessment/aftercare/travel/admin =3,500.32 is a planning proxy, not an observed visit count. The460 allowance needs itemization; volunteer/public resources and failed outreach require verification. No donor quote.

This review does not establish a verified marginal funding offer or a complete history of grants.

Donate

Opens the organization’s giving page. A general donation may not fund the specific activity modeled here; confirm allocation with the recipient.

6. Sources

1. Street Outreach Services. SFCCC. Provider disclosure. Published: Undated; retrieved: 2026-09-07.
2. Provider statement on SOS services. SFCCC. Provider-authored release; not outcome evaluation. Published: 2024-12-03; retrieved: 2026-09-07.
3. Morrell1998 community leg-ulcer trial. BMJ. Primary randomized trial. Published: 1998; retrieved: 2026-09-07.
4. Wong2023 venous-ulcer health utility. Health Science Reports. Noncausal health-state comparison. Published: 2023; retrieved: 2026-09-07.
5. Federal programs. SFCCC. Public funding overlap. Published: Undated; retrieved: 2026-09-07.
6. Registered Nurse2320 pay scale. City and County of SF. Labor cost orientation, not SOS quote. Published: 2026; retrieved: 2026-09-07.

Annual expenses: years and sources

Average annual expenses (three consecutive fiscal years): $14,909,462. Organization size is separate from the modeled cost-effectiveness of a donation.

San Francisco Community Clinic Consortium

Form 990 reported whole-entity expenses; includes program, administration and fundraising costs, but excludes costs netted against revenue.

• FY2025: $14,155,011
• FY2024: $15,257,974
• FY2023: $15,315,402

Fiscal years ended June 30. Whole consortium filing expenses, including grants; not the combined budgets of member clinics or the Street Outreach Services program alone.